Lountzis Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-57
Closed -$4.32K 70
2021
Q3
$4.32K Hold
57
﹤0.01% 83
2021
Q2
$4K Sell
57
-3
-5% -$223 ﹤0.01% 78
2021
Q1
$4.43K Hold
60
﹤0.01% 77
2020
Q4
$5K Hold
60
﹤0.01% 78
2020
Q3
$5K Hold
60
﹤0.01% 66
2020
Q2
$4K Buy
+60
New +$4.52K ﹤0.01% 68

Other funds holding MRK

Lountzis Asset Management's MRK Position: Q4 2021 in Review

Lountzis Asset Management sold out of Merck (MRK) in Q4 2021, closing a stake of 57 shares — an estimated $4.32K sold.

Lountzis Asset Management first reported a position in MRK in Q2 2020 and held it in 6 quarters. The position peaked at $5K in Q4 2020. 2,902 funds tracked by Wall St. Rank hold MRK as of Q4 2021.

  • Lountzis Asset Management reported no remaining Merck position as of Q4 2021 after selling out during the quarter.
  • Lountzis Asset Management sold 57 Merck shares in Q4 2021, an estimated $4.32K.
  • Lountzis Asset Management first reported a position in Merck in Q2 2020 and held it in 6 quarters.
  • Lountzis Asset Management's Merck position peaked at $5K in Q4 2020.
  • 2,902 funds tracked by Wall St. Rank held Merck as of Q4 2021.

Based on Lountzis Asset Management's 13F filing for Q4 2021, filed 26 Jan 2022.